bioAffinity Technologies (BIAF) Institutional Ownership $0.23 -0.02 (-8.66%) Closing price 04:00 PM EasternExtended Trading$0.24 +0.01 (+4.25%) As of 06:16 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for bioAffinity Technologies (NASDAQ:BIAF)CurrentInstitutional OwnershipPercentage1.64%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$23.94KNumber ofInstitutional Sellers(last 12 months)0 Get BIAF Insider Trade Alerts Want to know when executives and insiders are buying or selling bioAffinity Technologies stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address bioAffinity Technologies Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails1/30/2025Sheaff Brock Investment Advisors LLC46,304$42K0.0%+131.5%0.297% 8/9/2024 Renaissance Technologies LLC22,967$50K0.0%-38.8%0.197% 8/8/2024 Ground Swell Capital LLC22,864$49K0.0%N/A0.196% (Data available from 1/1/2016 forward) BIAF Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of BIAF shares? During the previous two years, the following institutional investors and hedge funds held shares of bioAffinity Technologies shares: Renaissance Technologies LLC ($50K), and Ground Swell Capital LLC ($49K), Sheaff Brock Investment Advisors LLC ($42K).Learn more on bioAffinity Technologies' institutional investors. What percentage of bioAffinity Technologies' stock is owned by institutional investors? 1.64% of bioAffinity Technologies' stock is owned by institutional investors. Learn more on BIAF's institutional investor holdings. Which institutional investors have been buying bioAffinity Technologies' stock? The following institutional investors have purchased bioAffinity Technologies' stock in the last 24 months: Sheaff Brock Investment Advisors LLC ($26.30K), and Ground Swell Capital LLC ($22.86K). How much institutional buying is happening at bioAffinity Technologies? Institutional investors have bought a total of 26,304 shares in the last 24 months. This purchase volume represents approximately $23.94K in transactions. Related Companies Data Storage Institutional Ownership CISO Global Institutional Ownership CTRL Group Institutional Ownership comScore Institutional Ownership Stran & Company, Inc. Institutional Ownership SPAR Group Institutional Ownership Luna Innovations Institutional Ownership Star Fashion Culture Institutional Ownership GEE Group Institutional Ownership FlexShopper Institutional Ownership This page (NASDAQ:BIAF) was last updated on 8/15/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding bioAffinity Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share bioAffinity Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access